At the World Glaucoma Congress (WGC) in Rome, Italy this summer, Ciliatech presented preliminary results of the second 2-year postoperative clinical trial (SAFARI Ⅱ) on its Cilioscleral Interposition Device (CID). The device, a 26% hydrophilic acrylic implant, is designed to lower intraocular pressure without entering the anterior chamber and without bleb…
I am delighted to announce the appointment of Mandy Robinson to the position of Senior Surgical Glaucoma Sales Specialist, UK & Ireland reporting to myself ....
We are thrilled to formally announce the appointment of Eleticia Szozda (Ele’) to the position of Global Surgical Training Consultant to support the surgical training ....
We are delighted to announce the appointment of Denise Cole to the position of Surgical Glaucoma Specialist, UK & Ireland. Denise brings deep surgical experience ....
This site is only for the use of professionals associated with the field of Ophthalmology and is not intended for patients.
